PF-Atlas › Исследования › Kidney Crossover
Исследования: Kidney Crossover (20)
20 публикаций в теме «Kidney Crossover», проиндексированных PF-Atlas из PubMed и мировых журналов.
Межзаболеваемые исследования. Эти работы относятся к смежным фибротическим, онкологическим или регенеративным областям и отслеживаются ради механистической значимости для ИЛФ. Они не являются прямым доказательством лечения идиопатического легочного фиброза.
- Luling Anshen Granules, a Novel Traditional Chinese Medicine formulation, Mitigates Renal Fibrosis in Mice with Chronic Renal Failure by Suppressing the Wnt/β-catenin Signaling Pathway. · Applied biochemistry and biotechnology · 2026
- iMSC-secreted factors preserve renal capillary networks and ameliorate fibrosis by interrupting the macrophage STING/CD8 T cell axis in ischemic kidney disease. · Stem cell research & therapy · 2026
- Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions. · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
- Leocarpinolide B alleviates epithelial tubular mitochondrial dysfunction via macrophage exosomal miR-204-5p/TFAM axis in AKI-CKD transition. · Journal of nanobiotechnology · 2026
- Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study. · Nature medicine · 2026
- Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits. · Lancet (London, England) · 2026
- Effects and mechanisms of theabrownin from black tea in improving hyperuricemia: Evidence from animal study and clinical trial. · International journal of biological macromolecules · 2025
- Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis. · Naunyn-Schmiedeberg's archives of pharmacology · 2025
- TITAL: targeting renal fibrosis with sulforaphane-a promising therapeutic strategy. · International urology and nephrology · 2025
- Radiation-Induced Nephrotoxicity: Role of Sphingomyelin Phosphodiesterase Acid-like 3b. · International journal of radiation oncology, biology, physics · 2025
- Oral administration of silicon-based agents attenuates renal fibrosis. · Biochemical and biophysical research communications · 2025
- Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents. · International immunopharmacology · 2025
- Real-world safety of Symdeko: insights from the food and drug administration adverse event reporting system. · Frontiers in medicine · 2025
- Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. · Lancet (London, England) · 2025
- The role of lncRNAs in AKI and CKD: Molecular mechanisms, biomarkers, and potential therapeutic targets. · Genes & diseases · 2025
- The Role of Renin-Angiotensin System in Diabetic Nephropathy: An Update. · Mini reviews in medicinal chemistry · 2025
- Bibliometric analysis of literature on natural medicines against chronic kidney disease from 2001 to 2024. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
- Finerenone in Heart Failure-A Novel Therapeutic Approach. · International journal of molecular sciences · 2024
- Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease. · International journal of molecular sciences · 2024
- [SGLT2 inhibitors - A novel treatment for congestive heart failure and chronic kidney disease]. · Laeknabladid · 2024
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.